ALX ONCOLOGY HOLDINGS INC Finance Lease, Interest Payment on Liability
ALX ONCOLOGY HOLDINGS INC (ALXO) reported Finance Lease, Interest Payment on Liability of $73.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FinanceLeaseInterestPaymentOnLiability · last filed 2026-08-06
- ALX ONCOLOGY HOLDINGS INC finance lease, interest payment on liability for the quarter ending 2026-06-30 was $28.00K, a 45.10% decline year-over-year.
- ALX ONCOLOGY HOLDINGS INC finance lease, interest payment on liability for the quarter ending 2026-03-31 was $45.00K, a 41.56% decline year-over-year.
- ALX ONCOLOGY HOLDINGS INC finance lease, interest payment on liability for the quarter ending 2025-12-31 was $39.00K, a 8.33% increase year-over-year.
- ALX ONCOLOGY HOLDINGS INC finance lease, interest payment on liability for the quarter ending 2025-09-30 was $32.00K, a 60.98% decline year-over-year.
- ALX ONCOLOGY HOLDINGS INC finance lease, interest payment on liability for fiscal 2025 was $199.00K, a 2.93% decline from fiscal 2024.
- ALX ONCOLOGY HOLDINGS INC finance lease, interest payment on liability for fiscal 2024 was $205.00K, a 925.00% increase from fiscal 2023.
- ALX ONCOLOGY HOLDINGS INC finance lease, interest payment on liability for fiscal 2023 was $20.00K, a 150.00% increase from fiscal 2022.
- ALX ONCOLOGY HOLDINGS INC finance lease, interest payment on liability for fiscal 2022 was $8.00K, a 27.27% decline from fiscal 2021.
| Period end | Finance Lease, Interest Payment on Liability 3 month | Finance Lease, Interest Payment on Liability 6 month | Finance Lease, Interest Payment on Liability 9 month | Finance Lease, Interest Payment on Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $73.00K 10-Q · filed 2026-08-06 | $112.00K derived: sum of 3 quarters · filed 2026-08-06 | $144.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $45.00K 10-Q · filed 2026-05-08 | $84.00K derived: sum of 2 quarters · filed 2026-05-08 | $116.00K derived: sum of 3 quarters · filed 2026-05-08 | $167.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $71.00K derived: sum of 2 quarters · filed 2026-03-09 | $122.00K derived: sum of 3 quarters · filed 2026-08-06 | $199.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $83.00K derived: sum of 2 quarters · filed 2026-08-06 | $160.00K 10-Q · filed 2025-11-07 | $196.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $128.00K 10-Q · filed 2026-08-06 | $164.00K derived: sum of 3 quarters · filed 2026-08-06 | $246.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $77.00K 10-Q · filed 2026-05-08 | $113.00K derived: sum of 2 quarters · filed 2026-05-08 | $195.00K derived: sum of 3 quarters · filed 2026-05-08 | $241.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $118.00K derived: sum of 2 quarters · filed 2026-03-09 | $164.00K derived: sum of 3 quarters · filed 2026-03-09 | $205.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | $82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $128.00K derived: sum of 2 quarters · filed 2025-11-07 | $169.00K 10-Q · filed 2025-11-07 | $186.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $87.00K 10-Q · filed 2025-08-12 | $104.00K derived: sum of 3 quarters · filed 2026-03-09 | $105.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-03-31 | $41.00K 10-Q · filed 2025-05-08 | $58.00K derived: sum of 2 quarters · filed 2026-03-09 | $59.00K derived: sum of 3 quarters · filed 2026-03-09 | $60.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2023-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $18.00K derived: sum of 2 quarters · filed 2026-03-09 | $19.00K derived: sum of 3 quarters · filed 2026-03-09 | $20.00K 10-K · filed 2026-03-09 |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.00K derived: sum of 2 quarters · filed 2024-11-07 | $3.00K 10-Q · filed 2024-11-07 | $4.00K derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $2.00K 10-Q · filed 2024-08-12 | $3.00K derived: sum of 3 quarters · filed 2025-03-06 | $6.00K derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-03-31 | $1.00K 10-Q · filed 2024-05-09 | $2.00K derived: sum of 2 quarters · filed 2025-03-06 | $5.00K derived: sum of 3 quarters · filed 2025-03-06 | $6.00K derived: sum of 4 quarters · filed 2025-03-06 |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $4.00K derived: sum of 2 quarters · filed 2025-03-06 | $5.00K derived: sum of 3 quarters · filed 2025-03-06 | $8.00K 10-K · filed 2025-03-06 |
| 2022-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $4.00K derived: sum of 2 quarters · filed 2023-11-13 | $7.00K 10-Q · filed 2023-11-13 | $11.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $4.00K 10-Q · filed 2023-08-10 | $8.00K derived: sum of 3 quarters · filed 2024-03-07 | $12.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $3.00K 10-Q · filed 2023-05-11 | $7.00K derived: sum of 2 quarters · filed 2024-03-07 | $11.00K derived: sum of 3 quarters · filed 2024-03-07 | |
| 2021-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $8.00K derived: sum of 2 quarters · filed 2024-03-07 | $11.00K 10-K · filed 2024-03-07 | |
| 2021-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $7.00K 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $3.00K 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |